11606

    509079

    GUFICBIO

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GUFIC BIOSCIENCES LTD. Share Price Today

    GUFIC BIOSCIENCES LTD. is currently trading at ₹421.4, up by ₹17.04 from the previous close. The stock touched an intraday high of ₹423.25 and a low of ₹404.65 during the latest trading session. Over the past one year, GUFIC BIOSCIENCES LTD. has delivered a return of 16.82%, while the stock has gained 10.77% in the last one month.

    GUFIC BIOSCIENCES LTD. performance

    Today’s low Today’s high
    ₹ 404.65 ₹ 423.25
    ₹ 421.40
    52 week low 52 week high
    ₹ 268.00 ₹ 448.00
    ₹ 421.40
    Open Price ₹ 404.65
    Prev. Close ₹ 404.35
    Volume (Shares) 266330.00
    Total traded value ₹ 1122.31
    Upper Circuit ₹ 485.20
    Lower Circuit ₹ 323.50
    info

    Investment Returns

    Over 1 Month 10.77% Over 3 Months 40.91% Over 6 Months 34.46% Over 1 Year 16.82%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GUFIC BIOSCIENCES LTD. fundamentals


    • Market cap (Cr) 4,225.90
    • P/E Ratio (TTM) 67.02
    • Beta 0.67
    • Book Value / share 66.23
    • Return on equity 12.33%
    • EPS (TTM) 6.30
    • Dividend yield 0.02%
    • Net profit/quarter (Cr) 20.57
    info icon alternate text
    • Market cap (Cr) 4,234.40
    • P/E Ratio (TTM) 67.02
    • Beta 0.72
    • Book Value / share 66.23
    • Return on equity 12.33%
    • EPS (TTM) 6.30
    • Dividend yield 0.02%
    • Net profit/quarter (Cr) 20.57
    info icon alternate text

    GUFIC BIOSCIENCES LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 252.05
    Operating Expense 223.23
    Net Profit 20.57
    Net Profit Margin (%) 8.16
    Earnings Per Share (EPS) 2.05
    EBITDA 44.72
    Effective Tax Rate (%) 25.51
    Particulars DEC 2025 (Values in Cr)
    Revenue 231.09
    Operating Expense 210.83
    Net Profit 15.56
    Net Profit Margin (%) 6.73
    Earnings Per Share (EPS) 1.55
    EBITDA 37.10
    Effective Tax Rate (%) 26.08
    Particulars SEP 2025 (Values in Cr)
    Revenue 230.42
    Operating Expense 211.98
    Net Profit 14.94
    Net Profit Margin (%) 6.48
    Earnings Per Share (EPS) 1.49
    EBITDA 37.87
    Effective Tax Rate (%) 27.22
    Particulars JUN 2025 (Values in Cr)
    Revenue 226.91
    Operating Expense 211.53
    Net Profit 12.07
    Net Profit Margin (%) 5.31
    Earnings Per Share (EPS) 1.20
    EBITDA 33.23
    Effective Tax Rate (%) 25.79
    Particulars MAR 2025 (Values in Cr)
    Revenue 205.02
    Operating Expense 194.62
    Net Profit 7.97
    Net Profit Margin (%) 3.88
    Earnings Per Share (EPS) 0.80
    EBITDA 27.02
    Effective Tax Rate (%) 26.06
    Particulars MAR 2026 (Values in Cr)
    Revenue 940.48
    Operating Expense 857.57
    Net Profit 63.15
    Net Profit Margin (%) 6.71
    Earnings Per Share (EPS) 6.30
    EBITDA 152.93
    Effective Tax Rate (%) 26.13
    Particulars MAR 2025 (Values in Cr)
    Revenue 819.81
    Operating Expense 728.99
    Net Profit 69.93
    Net Profit Margin (%) 8.53
    Earnings Per Share (EPS) 6.97
    EBITDA 140.01
    Effective Tax Rate (%) 25.93
    Particulars MAR 2024 (Values in Cr)
    Revenue 806.67
    Operating Expense 693.17
    Net Profit 86.14
    Net Profit Margin (%) 10.67
    Earnings Per Share (EPS) 8.74
    EBITDA 148.05
    Effective Tax Rate (%) 25.53
    Particulars MAR 2023 (Values in Cr)
    Revenue 690.62
    Operating Expense 586.47
    Net Profit 79.70
    Net Profit Margin (%) 11.54
    Earnings Per Share (EPS) 8.22
    EBITDA 137.22
    Effective Tax Rate (%) 25.31
    Particulars MAR 2022 (Values in Cr)
    Revenue 779.16
    Operating Expense 655.43
    Net Profit 95.84
    Net Profit Margin (%) 12.30
    Earnings Per Share (EPS) 9.89
    EBITDA 151.14
    Effective Tax Rate (%) 24.44
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 59.93
    ROE % 12.29
    ROCE % 12.86
    Total Debt to Total Equity 0.59
    EBITDA Margin 17.04
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 53.11
    ROE % 16.17
    ROCE % 14.95
    Total Debt to Total Equity 0.63
    EBITDA Margin 18.53
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 59.96
    ROE % 12.33
    ROCE % 12.88
    Total Debt to Total Equity 0.59
    EBITDA Margin 17.08
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 53.11
    ROE % 19.57
    ROCE % 16.70
    Total Debt to Total Equity 0.76
    EBITDA Margin 18.53
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 35.88
    ROE % 25.84
    ROCE % 21.87
    Total Debt to Total Equity 0.65
    EBITDA Margin 19.87
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 27.76
    ROE % 43.31
    ROCE % 43.99
    Total Debt to Total Equity 0.28
    EBITDA Margin 19.40
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 17.89
    ROE % 29.22
    ROCE % 27.51
    Total Debt to Total Equity 0.62
    EBITDA Margin 17.97
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 29.02
    Total Assets 1169.36
    Total Liabilities 1169.36
    Total Equity 601.07
    Share Outstanding 10
    Price to Book Ratio 5.61
    Return on Assets (%) 5.95
    Return on Capital (%) 7.64
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.48
    Total Assets 1092.54
    Total Liabilities 1092.54
    Total Equity 532.56
    Share Outstanding 10
    Price to Book Ratio 5.33
    Return on Assets (%) 7.88
    Return on Capital (%) 10.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 28.20
    Total Assets 1169.62
    Total Liabilities 1169.62
    Total Equity 601.36
    Share Outstanding 10
    Price to Book Ratio 5.61
    Return on Assets (%) 5.97
    Return on Capital (%) 7.67
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.47
    Total Assets 1092.54
    Total Liabilities 1092.54
    Total Equity 532.56
    Share Outstanding 10
    Price to Book Ratio 5.33
    Return on Assets (%) 7.88
    Return on Capital (%) 10.14
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 46.68
    Total Assets 861.15
    Total Liabilities 861.15
    Total Equity 347.80
    Share Outstanding 9
    Price to Book Ratio 5.20
    Return on Assets (%) 9.25
    Return on Capital (%) 12.09
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 26.57
    Total Assets 521.40
    Total Liabilities 521.40
    Total Equity 269.11
    Share Outstanding 9
    Price to Book Ratio 8.97
    Return on Assets (%) 18.38
    Return on Capital (%) 29.01
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 13.17
    Total Assets 392.06
    Total Liabilities 392.06
    Total Equity 173.43
    Share Outstanding 9
    Price to Book Ratio 6.39
    Return on Assets (%) 11.28
    Return on Capital (%) 19.33
    Particulars MAR 2025 (Values in Cr)
    Net Income 69.64
    Cash from Operations 145.37
    Cash from Investing -70.77
    Cash from Financing -37.20
    Net change in Cash 14.58
    Free Cash Flow 145.37
    Particulars MAR 2024 (Values in Cr)
    Net Income 86.13
    Cash from Operations 19.58
    Cash from Investing -102.38
    Cash from Financing 82.38
    Net change in Cash -27.46
    Free Cash Flow 19.58
    Particulars MAR 2025 (Values in Cr)
    Net Income 69.93
    Cash from Operations 145.58
    Cash from Investing -71.79
    Cash from Financing -37.20
    Net change in Cash 13.78
    Free Cash Flow 145.58
    Particulars MAR 2024 (Values in Cr)
    Net Income 86.13
    Cash from Operations 19.58
    Cash from Investing -102.39
    Cash from Financing 82.38
    Net change in Cash -27.47
    Free Cash Flow 19.58
    Particulars MAR 2023 (Values in Cr)
    Net Income 79.70
    Cash from Operations 1.10
    Cash from Investing -190.72
    Cash from Financing 234.30
    Net change in Cash 16.99
    Free Cash Flow 1.10
    Particulars MAR 2022 (Values in Cr)
    Net Income 95.84
    Cash from Operations 139.29
    Cash from Investing -94.58
    Cash from Financing -6.24
    Net change in Cash 5.40
    Free Cash Flow 139.29
    Particulars MAR 2021 (Values in Cr)
    Net Income 44.23
    Cash from Operations 96.65
    Cash from Investing -6.69
    Cash from Financing -78.61
    Net change in Cash 1.94
    Free Cash Flow 109.05
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 19.35 2.25 357.34 23.12 47.39
    BLISS GVS PHARMA LTD 477.10 38.41 4.24 5068.90 118.35 552.90
    CIPLA LTD. 1472.00 33.23 3.45 118914.83 1165.55 1672.20
    FERMENTA BIOTECH LTD. 559.55 26.17 4.05 1646.81 256.40 568.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 32.61 6.00 357.34 23.12 47.39
    AMRUTAJAN HEALTH LTD 522.95 23.44 4.08 1511.88 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8188.15 107.01 23.45 20470.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 477.10 51.63 4.38 5068.90 118.35 552.90

    GUFIC BIOSCIENCES LTD. shareholding pattern

    Holding
    23.35%
    72.5%
    0.46%
    3.67%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    GUFIC BIOSCIENCES LTD. Technicals Summary

    421.40 4.21 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 404.40
    • 26 Days 388.30
    • 10 Days 397.60
    • 50 Days 373.80
    • 12 Days 396.10
    • 100 Days 353.60
    • 20 Days 391.50
    • 200 Days 345.10
    402.17 PIVOT
    First Support 396.33 First Resistance 410.18 Second Support 388.32 Second Resistance 416.02 Third Support 382.48 Third Resistance 424.03
    RSI 68.70 ADX 11.50 MACD 7.78 Williams % R -3.05 Commodity Channel Index (CCI) 228.20
    Date 2026-08-07 Week 51128.00 Same Day 145183.00 Month 46423.00
    1 Year 0.68 3 Year 0.75
    Over 1 Month
    10.77% down
    Over 1 Year
    16.82% down
    Over 3 Months
    40.91% down
    Over 3 Years
    15.44% down
    Over 6 Months
    34.46% down
    Over 5 Years
    17.49% down

    GUFIC BIOSCIENCES LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Sep 2025 0.1 Final 22 Sep 2025 Equity shares
    17 Sep 2024 0.1 Final 19 Sep 2024 Equity shares
    21 Sep 2023 0.1 Final 21 Sep 2023 Equity shares
    24 Aug 2022 0.1 Final 25 Aug 2022 Equity shares
    09 Sep 2021 0.1 Final 14 Sep 2021 Equity shares
    03 Nov 2020 0.05 Final 05 Nov 2020 Equity shares
    20 Sep 2019 0.05 Final 24 Sep 2019 Equity shares
    19 Sep 2018 0.05 Final 22 Sep 2018 Equity shares
    28 Aug 2017 0.05 Final 30 Aug 2017 Equity shares
    19 Sep 2016 0.05 Final 21 Sep 2016 Equity shares
    22 Sep 2015 0.05 Final 24 Sep 2015 Equity shares
    18 Sep 2014 0.05 Final 22 Sep 2014 Equity shares
    02 Sep 2013 0.05 Final 23 Sep 2013 Equity shares
    16 Aug 2012 0.05 Final 20 Aug 2012 Equity shares
    16 Sep 2011 0.05 Final 20 Sep 2011 Equity shares
    20 Sep 2010 0.05 Final 22 Sep 2010 Equity shares
    17 Sep 2009 0.05 Final 19 Sep 2009 Equity shares
    11 Dec 2008 0.05 Final 15 Dec 2008 Equity shares
    19 Mar 2008 0.05 Final 25 Mar 2008 Equity shares
    20 Sep 2006 0.0 Final 22 Sep 2006 Equity shares
    22 Sep 2005 0.0 Final 24 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    04 Nov 2000 19 Oct 2000 5:2
    04 Nov 2000 09 Oct 2000 5:2
    Ex-Date Old FV NEW FV Record Date
    29 Oct 2002 10.0 1.0 08 Nov 2002
    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Sep 2025 0.1 Final 22 Sep 2025 Equity shares
    17 Sep 2024 0.1 Final 19 Sep 2024 Equity shares
    21 Sep 2023 0.1 Final 21 Sep 2023 Equity shares
    24 Aug 2022 0.1 Final 25 Aug 2022 Equity shares
    09 Sep 2021 0.1 Final 14 Sep 2021 Equity shares
    03 Nov 2020 0.05 Final 05 Nov 2020 Equity shares
    20 Sep 2019 0.05 Final 24 Sep 2019 Equity shares
    19 Sep 2018 0.05 Final 22 Sep 2018 Equity shares
    28 Aug 2017 0.05 Final 30 Aug 2017 Equity shares
    19 Sep 2016 0.05 Final 21 Sep 2016 Equity shares
    22 Sep 2015 0.05 Final 24 Sep 2015 Equity shares
    18 Sep 2014 0.05 Final 22 Sep 2014 Equity shares
    02 Sep 2013 0.05 Final 23 Sep 2013 Equity shares
    16 Aug 2012 0.05 Final 20 Aug 2012 Equity shares
    16 Sep 2011 0.05 Final 20 Sep 2011 Equity shares
    20 Sep 2010 0.05 Final 22 Sep 2010 Equity shares
    17 Sep 2009 0.05 Final 19 Sep 2009 Equity shares
    11 Dec 2008 0.05 Final 15 Dec 2008 Equity shares
    19 Mar 2008 0.05 Final 25 Mar 2008 Equity shares
    20 Sep 2006 0.0 Final 22 Sep 2006 Equity shares
    22 Sep 2005 0.0 Final 24 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    04 Nov 2000 19 Oct 2000 5:2
    04 Nov 2000 09 Oct 2000 5:2
    Ex-Date Old FV NEW FV Record Date
    29 Oct 2002 10.0 1.0 08 Nov 2002

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Gufic BioSciences Ltd?

    Answer Field

    Gufic BioSciences Ltd share price is for NSE ₹ 421.40 & for BSE ₹ 420.00 as on Aug 07 2026 03:30 PM.

    What is the Market Cap of Gufic BioSciences Ltd Share?

    Answer Field

    The market cap of Gufic BioSciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 03:30 PM.

    What is the 52 Week High and Low of Gufic BioSciences Ltd?

    Answer Field

    The 52 Week High and Low of Gufic BioSciences Ltd for NSE is ₹ 448.00 and ₹ 268.00 and for BSE is ₹ 447.85 and ₹ 267.50.

    What is 1 year return for Gufic BioSciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 16.82%.

    What is the P/E Ratio of Gufic BioSciences Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM the price-to-earnings (PE) ratio for Gufic BioSciences Ltd share is 67.02.

    What is the PB ratio of Gufic BioSciences Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM, the price-to-book (PB) ratio for Gufic BioSciences Ltd share is 66.23.

    How to Buy Gufic BioSciences Ltd Share?

    Answer Field

    You can trade in Gufic BioSciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Gufic BioSciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Gufic BioSciences Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Gufic BioSciences Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |